web analytics
CBD

Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact

United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from the COVID-19 pandemic. GW reported revenue of $121.3 million for the quarter ended June 30 – about the same as the previous period. GW’s quarterly net loss rose slightly to $8.8 million. By product, Epidiolex […]

Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs



Source: Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact


Tags

About the author

Steve Morrison

Steve Morrison

Steve serves as the founding editor of Hemp Stash News. With over 10 years experience in the news publishing business he decided to extend his vast portfolio by editing and publishing news about the Cannabis industry. Steve has a bachelor's degree in Journalism from the Northern Arizona University.

Steve can be reached out at: Steve.Morrison@hempstashnews.com

Add Comment

Click here to post a comment